MRK

Merck & Co., Inc. · Healthcare · Drug Manufacturers - General
$135.18
-0.79 (-0.58%)
Mkt Cap: 333.87B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield4.7%
Dividend YieldN/A
Market Cap333.87B
Volume8.12M
Recent News
AZN Ends NSCLC Study for Bispecific Antibody Over Unlikely Success
zacks.com · 2026-08-18
PPH vs. IYH: Which Healthcare Fund Is the Better Buy?
fool.com · 2026-08-18
Cisco, Merck, Cheniere Energy And More: CNBC's ‘Final Trades'
benzinga.com · 2026-08-18
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.
fool.com · 2026-08-18
Merck & Co., Inc. $MRK Shares Sold by EverSource Wealth Advisors LLC
defenseworld.net · 2026-08-18
5 Undervalued Winners Up To 6.8% And 15 Overvalued To Avoid Now
seekingalpha.com · 2026-08-18

Unlock the Full Deep Scan

9 AI agents analyze MRK across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →